AbClon

174900 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

AbClon updated a previously disclosed supply contract, now worth US$512K, about 33.3% of its recent annual revenue, running through Jul 2026.

Supply contract([Amended] Supply contract signed)· FILED 2026-07-07· RCEPT 20260707900267

US$512KContract value
33.3%vs. recent revenue
Jul 2026Throughfrom Mar 2026

Converted at 1 USD ≈ ₩1,519.86 (filing-date rate, 2026-07-07 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-07-22) →

What happened

AbClon updated a previously disclosed supply contract, now worth US$512K, about 33.3% of its recent annual revenue, running through Jul 2026.

For context, this single contract equals about 33.3% of the company's most recent annual revenue.

CounterpartyDisclosed
Contract valueUS$512K
vs. recent revenue33.3%
ThroughJul 2026 (from Mar 2026)
Filed2026-07-07, [Amended] Supply contract signed
SourceDART rcept 20260707900267 → open original filing

Versions of this filing

  1. 2026-03-09Original
  2. 2026-07-07Amendment 1 (this page)
  3. 2026-07-22Amendment 2

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-07 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.